Cargando…
2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma
Adrenocortical carcinoma (ACC) is a rare aggressive tumor with poor prognosis when metastatic at diagnosis. The tumor biology is still mostly unclear, justifying the limited specificity and efficacy of the anti-cancer drugs currently available. This study reports the first proteomic analysis of ACC...
Autores principales: | Poli, Giada, Ceni, Elisabetta, Armignacco, Roberta, Ercolino, Tonino, Canu, Letizia, Baroni, Gianna, Nesi, Gabriella, Galli, Andrea, Mannelli, Massimo, Luconi, Michaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467395/ https://www.ncbi.nlm.nih.gov/pubmed/25691058 |
Ejemplares similares
-
Metformin as a new anti-cancer drug in adrenocortical carcinoma
por: Poli, Giada, et al.
Publicado: (2016) -
Prognostic and Monitoring Value of Circulating Tumor Cells in Adrenocortical Carcinoma: A Preliminary Monocentric Study
por: Cantini, Giulia, et al.
Publicado: (2020) -
New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer
por: Salvianti, Francesca, et al.
Publicado: (2017) -
Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer
por: Cantini, Giulia, et al.
Publicado: (2021) -
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling
por: Cantini, Giulia, et al.
Publicado: (2008)